
A Landmark Year for FDA-Approved Therapies for Acute Myeloid Leukemia
Author(s) -
Omar AbdelWahab
Publication year - 2018
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v15.1.8155
Subject(s) - medicine , myeloid leukemia , landmark , pharmacology , computer science , artificial intelligence